Integrative public data-mining pipeline for the validation of novel independent prognostic biomarkers for lung adenocarcinoma

Author:

Ghandili Susanne12,Oqueka Tim1,Schmitz Melanie12,Janning Melanie23,Körbelin Jakob12,Westphalen C Benedikt4,P Haen Sebastian2,Loges Sonja23,Bokemeyer Carsten2,Klose Hans1,K Hennigs Jan12ORCID

Affiliation:

1. Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

2. Department of Medicine II – Oncology, Hematology, Bone Marrow Transplantation, Center of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

3. Institute of Tumor Biology, Center for Experimental Medicine, Hubertus Wald Tumorzentrum – University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

4. Department of Medicine III & Comprehensive Cancer Center, Ludwig-Maximilians-University, Munich, Germany

Abstract

Aim: We aimed to develop a candidate-based integrative public data mining strategy for validation of novel prognostic markers in lung adenocarcinoma. Materials & methods: An in silico approach integrating meta-analyses of publicly available clinical information linked RNA expression, gene copy number and mutation datasets combined with independent immunohistochemistry and survival datasets. Results: After validation of pipeline integrity utilizing data from the well-characterized prognostic factor Ki-67, prognostic impact of the calcium- and integrin-binding protein, CIB1, was analyzed. CIB1 was overexpressed in lung adenocarcinoma which correlated with pathological tumor and pathological lymph node status and impaired overall/progression-free survival. In multivariate analyses, CIB1 emerged as UICC stage-independent risk factor for impaired survival. Conclusion: Our pipeline holds promise to facilitate further identification and validation of novel lung cancer-associated prognostic markers.

Publisher

Future Medicine Ltd

Subject

Biochemistry (medical),Clinical Biochemistry,Drug Discovery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3